|
|
|
Insider
Information: |
Kolchinsky Peter |
Relationship: |
Director, 10% Owner |
City: |
Boston |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
21 |
|
Direct
Shares |
6,648,738 |
|
Indirect Shares
|
89,615,900 |
|
|
Direct
Value |
$30,628,641 |
|
|
Indirect Value
|
$977,264,948 |
|
|
Total
Shares |
96,264,638 |
|
|
Total
Value |
$1,007,893,589 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
1
|
0
|
Stock
price went up :
|
1
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
1.0
|
0.0
|
Percentage
Gain/Loss : |
14.5%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Aradigm Corp |
ARDM |
10% Owner |
2007-03-01 |
0 |
2008-01-15 |
7,681,410 |
Premium* |
|
Curis Inc |
CRIS |
10% Owner |
2008-04-15 |
0 |
2008-04-15 |
6,250,564 |
Premium* |
|
Sequenom Inc |
SQNM |
10% Owner |
|
0 |
2008-06-06 |
4,617,766 |
Premium* |
|
Biospecifics Technologies Corp |
BSTC |
10% Owner |
2008-12-29 |
0 |
2009-04-14 |
825,844 |
Premium* |
|
Lipid Sciences Inc |
LIPD |
10% Owner |
2008-03-27 |
0 |
2008-03-27 |
3,705,312 |
Premium* |
|
Achillion Pharmaceuticals Inc |
ACHN |
10% Owner |
2013-09-30 |
4,816,562 |
2014-09-11 |
13,000,000 |
Premium* |
|
Sangamo Biosciences Inc |
SGMO |
Former 10% Owner |
2014-08-01 |
1,829,426 |
2013-07-17 |
0 |
Premium* |
|
Aclaris Therapeutics, Inc. |
ACRS |
10% Owner |
2015-10-07 |
0 |
2015-10-21 |
2,314,942 |
Premium* |
|
Ra Pharmaceuticals, Inc. |
RARX |
Director, 10% Owner |
2016-10-31 |
0 |
2020-04-02 |
0 |
Premium* |
|
Kalvista Pharmaceuticals Inc |
KALV |
Director, 10% Owner |
2016-11-21 |
0 |
2017-10-12 |
1,441,070 |
Premium* |
|
G1 Therapeutics Inc |
GTHX |
Fmr 10% Owner See Foot... |
2017-05-22 |
0 |
2017-05-22 |
2,684,244 |
Premium* |
|
Kala Pharmaceuticals, Inc. |
KALA |
Director, 10% Owner |
2017-07-25 |
0 |
2020-03-13 |
10,874,613 |
Premium* |
|
Wave Life Sciences Ltd. |
WVE |
Director, 10% Owner |
2017-11-13 |
0 |
2019-01-24 |
7,775,207 |
Premium* |
|
Dicerna Pharmaceuticals Inc |
DRNA |
Director |
2017-12-18 |
0 |
2019-12-02 |
0 |
Premium* |
|
Eidos Therapeutics, Inc. |
EIDX |
10% Owner |
2018-06-22 |
0 |
2018-06-22 |
2,162,671 |
Premium* |
|
Arvinas Holding Company, Llc |
ARVN |
Former 10% Owner |
2018-10-01 |
0 |
2018-10-01 |
3,138,412 |
Premium* |
|
Synthorx, Inc. |
THOR |
Director, 10% Owner |
2018-12-11 |
0 |
2020-01-23 |
0 |
Premium* |
|
Satsuma Pharmaceuticals, Inc. |
STSA |
Former 10% Owner |
2019-09-17 |
0 |
2023-06-08 |
0 |
Premium* |
|
Rhythm Pharmaceuticals, Inc. |
RYTM |
10% Owner |
|
0 |
2019-10-16 |
5,422,312 |
Premium* |
|
Forma Therapeutics Holdings, Inc., |
FMTX |
Director, 10% Owner |
2021-06-17 |
2,750 |
2021-06-17 |
9,011,651 |
Premium* |
|
Solid Biosciences Inc |
SLDB |
Director, 10% Owner |
|
0 |
2020-12-10 |
8,709,882 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
207 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 9
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
SQNM |
Sequenom Inc |
10% Owner |
|
2008-06-06 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
4,617,766 |
|
- |
|
SGMO |
Sangamo Biosciences Inc |
10% Owner |
|
2013-06-26 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
3,626,503 |
|
- |
|
ACHN |
Achillion Pharmaceuticals... |
10% Owner |
|
2013-07-15 |
3/A |
IO |
$0.00 |
$0 |
D/D |
0 |
6,842,944 |
|
- |
|
ACHN |
Achillion Pharmaceuticals... |
10% Owner |
|
2013-09-30 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
11,657,061 |
|
- |
|
SGMO |
Sangamo Biosciences Inc |
10% Owner |
|
2013-12-11 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
4,028,362 |
|
- |
|
SGMO |
Sangamo Biosciences Inc |
10% Owner |
|
2014-01-29 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
3,683,002 |
|
- |
|
ACRS |
Aclaris Therapeutics, Inc... |
10% Owner |
|
2015-10-07 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
2,237,130 |
|
- |
|
RYTM |
Rhythm Pharmaceuticals, I... |
10% Owner |
|
2019-10-16 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
5,422,312 |
|
- |
|
SLDB |
Solid Biosciences Inc |
Director |
|
2020-12-10 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
8,709,882 |
|
% |
|
BSTC |
Biospecifics Technologies... |
10% Owner |
|
2009-04-13 |
4 |
B |
$18.05 |
$5,126 |
I/I |
284 |
824,944 |
1.5 |
- |
|
BSTC |
Biospecifics Technologies... |
10% Owner |
|
2008-12-23 |
4 |
B |
$20.00 |
$14,400 |
I/I |
700 |
780,346 |
1.5 |
- |
|
BSTC |
Biospecifics Technologies... |
10% Owner |
|
2009-04-14 |
4 |
B |
$18.50 |
$16,650 |
I/I |
900 |
825,844 |
1.5 |
- |
|
SGMO |
Sangamo Biosciences Inc |
Former 10% Owner |
|
2014-07-29 |
4 |
S |
$12.41 |
$17,464 |
D/D |
(1,407) |
1,966,786 |
0 |
- |
|
ACHN |
Achillion Pharmaceuticals... |
10% Owner |
|
2013-09-18 |
4 |
S |
$7.48 |
$17,413 |
D/D |
(2,328) |
5,037,018 |
0 |
- |
|
FMTX |
Forma Therapeutics Holdin... |
Director |
|
2021-06-17 |
4 |
A |
$0.00 |
$0 |
D/D |
2,750 |
2,750 |
0 |
- |
|
SGMO |
Sangamo Biosciences Inc |
Former 10% Owner |
|
2014-04-14 |
4 |
S |
$14.78 |
$45,165 |
D/D |
(3,055) |
4,720,578 |
0 |
- |
|
ACRS |
Aclaris Therapeutics, Inc... |
10% Owner |
|
2015-10-21 |
4 |
B |
$14.83 |
$45,976 |
I/I |
3,100 |
2,314,942 |
1.5 |
- |
|
ACHN |
Achillion Pharmaceuticals... |
10% Owner |
|
2013-07-29 |
4 |
S |
$6.95 |
$23,479 |
D/D |
(3,377) |
5,310,729 |
0 |
- |
|
SGMO |
Sangamo Biosciences Inc |
Former 10% Owner |
|
2014-04-10 |
4 |
S |
$15.67 |
$53,326 |
D/D |
(3,403) |
4,606,641 |
0 |
- |
|
ACHN |
Achillion Pharmaceuticals... |
10% Owner |
|
2013-08-21 |
4 |
S |
$6.87 |
$29,641 |
D/D |
(4,312) |
5,185,457 |
0 |
- |
|
SGMO |
Sangamo Biosciences Inc |
Former 10% Owner |
|
2013-07-23 |
4 |
S |
$9.37 |
$46,938 |
D/D |
(5,012) |
3,487,088 |
0 |
- |
|
SGMO |
Sangamo Biosciences Inc |
Former 10% Owner. |
|
2013-12-13 |
4 |
B |
$12.09 |
$60,921 |
D/D |
5,040 |
4,043,002 |
2.44 |
- |
|
BSTC |
Biospecifics Technologies... |
10% Owner |
|
2009-03-17 |
4 |
B |
$19.94 |
$106,579 |
I/I |
5,345 |
810,931 |
1.5 |
- |
|
BSTC |
Biospecifics Technologies... |
10% Owner |
|
2008-12-31 |
4 |
B |
$21.40 |
$116,610 |
I/I |
5,390 |
795,436 |
1.5 |
- |
|
BSTC |
Biospecifics Technologies... |
10% Owner |
|
2008-12-22 |
4 |
B |
$18.75 |
$111,289 |
I/I |
5,500 |
779,646 |
1.5 |
- |
|
207 Records found
|
|
Page 1 of 9 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|